TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
99,07 R$
arrow_upward
+1,33%(+1,30) 1K
28-sen, 20:23:55 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoTAKP34 tikeri uchun statistika yaratilmoqda...
Bozor kapitali
9,03 trln
Oʻrtacha hajm
36,00
Hajmi
0,00
52 haftalik eng yuqori
99,07 R$
52 haftalik eng past
70,80 R$
Muomaladagi aksiyalar
1,60 mlrd
Xodimlar soni
47 ming
Bozor kapitali
9,03 trln
Oʻrtacha hajm
36,00
Hajmi
0,00
52 haftalik eng yuqori
99,07 R$
52 haftalik eng past
70,80 R$
Muomaladagi aksiyalar
1,60 mlrd
Xodimlar soni
47 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Stock Traders Daily
·
1 kun oldin
(TAK) Movement Within Algorithmic Entry Frameworks
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Co Ltd BDR haqida
CEOChristophe Weber | Christophe Weber
Xodimlar soni47 ming
Asos solingan12-iyn, 1781
Bosh ofislar-
Sektor-
Veb-sayttakeda.com